Literature DB >> 3533882

The application of genetically engineered micro-organisms in the production of drugs.

S B Primrose.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3533882     DOI： 10.1111/j.1365-2672.1986.tb04263.x

Source DB:  PubMed          Journal:  J Appl Bacteriol        ISSN： 0021-8847


× No keyword cloud information.
  3 in total

1.  Inactivation of recombinant plasmid DNA from a human erythropoietin-producing mouse cell line grown on a large scale.

Authors:  M R Fibi; M Bröker; R Schulz; R Johannsen; G Zettlmeissl
Journal:  Appl Microbiol Biotechnol       Date:  1991-08       Impact factor: 4.813

2.  Recombinant Saccharomyces cerevisiae strain expressing a model cytochrome P450 in the rat digestive environment: viability and bioconversion activity.

Authors:  G Garrait; J F Jarrige; S Blanquet; E Beyssac; M Alric
Journal:  Appl Environ Microbiol       Date:  2007-04-06       Impact factor: 4.792

3.  Cell engineering and molecular pharming for biopharmaceuticals.

Authors:  M A Abdullah; Anisa Ur Rahmah; A J Sinskey; C K Rha
Journal:  Open Med Chem J       Date:  2008-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.